stearoyl alpha-lysolecithin has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jeong, SJ; Jung, DB; Jung, JH; Jung, SK; Kim, JH; Kim, SH; Lee, D; Lee, HJ; Sohn, EJ; Yun, M | 1 |
1 other study(ies) available for stearoyl alpha-lysolecithin and Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Article | Year |
---|---|
Inactivation of HDAC3 and STAT3 is critically involved in 1-stearoyl-sn-glycero-3-phosphocholine-induced apoptosis in chronic myelogenous leukemia K562 cells.
Topics: Acetylation; Apoptosis; bcl-X Protein; Cell Line, Tumor; Histone Deacetylases; Histones; HL-60 Cells; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lysophosphatidylcholines; Promoter Regions, Genetic; Protein Binding; Protein Tyrosine Phosphatase, Non-Receptor Type 6; RNA Interference; RNA, Small Interfering; STAT3 Transcription Factor | 2013 |